← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2003Last known activity
Jul 15, 2025
Timeline
1940s
- Jun 1, 1949
The Leukemia and Lymphoma Society— Founded
Drugs by trial phase (86 distinct, 63 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (51 own, 0 via acquisition)
Phase 1 (31 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Anemia, Refractory, with Excess of Blasts
- Blast Crisis
- Graft vs Host Disease
- Hodgkin Disease
- Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Mast-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Leukemia, Prolymphocytic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Monoclonal Gammopathy of Undetermined Significance
- Multiple Myeloma
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms
- Neoplasms, Plasma Cell
- Paraproteinemias
- Polycythemia
- Polycythemia Vera
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Primary Myelofibrosis
- Syndrome
- Thrombocythemia, Essential
- Thrombocytosis
- Vitamin D Deficiency
- Waldenstrom Macroglobulinemia
Recent trials (50)
- NCT06916767CollaboratorPhase 1Jul 15, 2025
- NCT06954805CollaboratorPhase 2Apr 14, 2025
- NCT06429449CollaboratorPhase 1Dec 31, 2024
- NCT06756308CollaboratorPhase 2Dec 24, 2024
- NCT06158828CollaboratorPhase 1/Phase 2Mar 31, 2024
- NCT06340737CollaboratorPhase 1Mar 29, 2024
- NCT06232655CollaboratorPhase 2Feb 8, 2024
- NCT06152809CollaboratorPhase 1Jan 31, 2024
- NCT06071624CollaboratorPhase 1Jan 31, 2024
- NCT05536349CollaboratorPhase 2Dec 20, 2022
- NCT03820817CollaboratorPhase 1May 15, 2019
- NCT03502577CollaboratorPhase 1Sep 30, 2018
- NCT02530034CollaboratorPhase 1Nov 1, 2016
- NCT02882321CollaboratorPhase 1Sep 29, 2016
- NCT02871323CollaboratorPhase 1Sep 1, 2016
Details
- Founded
- New York, NY, US Jun 1, 1949
- Last known activity
- Jul 15, 2025